These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 20272341)

  • 41. Para-anthrax; infection with organisms resembling Bacillus anthracis.
    EPSTEIN E
    Arch Derm Syphilol; 1948 Apr; 57(4):664-7. PubMed ID: 18886276
    [No Abstract]   [Full Text] [Related]  

  • 42. Meningitis due to bacillus anthracis.
    Gürcan S; Akata F; Kuloğlu F; Erdoğan S; Tuğrul M
    Yonsei Med J; 2005 Feb; 46(1):159-60. PubMed ID: 15744820
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Protective effect of Bacillus anthracis surface protein EA1 against anthrax in mice.
    Uchida M; Harada T; Enkhtuya J; Kusumoto A; Kobayashi Y; Chiba S; Shyaka A; Kawamoto K
    Biochem Biophys Res Commun; 2012 May; 421(2):323-8. PubMed ID: 22507985
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Efficacy of enterocin S760 in treatment of mice with anthrax infection due to Bacillus anthracis M-71].
    Svetoch EA; Borzilov AI; Eruslanov BV; Korobova OV; Kombarova TI; Levchuk VP; Teĭmurazov MG; Stepanshin IuG; Marinin LI; Diatlov IA
    Antibiot Khimioter; 2011; 56(9-10):13-8. PubMed ID: 22586898
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Effective antimicrobial regimens for use in humans for therapy of Bacillus anthracis infections and postexposure prophylaxis.
    Deziel MR; Heine H; Louie A; Kao M; Byrne WR; Basset J; Miller L; Bush K; Kelly M; Drusano GL
    Antimicrob Agents Chemother; 2005 Dec; 49(12):5099-106. PubMed ID: 16304178
    [TBL] [Abstract][Full Text] [Related]  

  • 46. From the Centers for Disease Control and Prevention. Updated recommendations for antimicrobial prophylaxis among asymptomatic pregnant women after exposure to Bacillus anthracis.
    JAMA; 2001 Nov; 286(19):2396-7. PubMed ID: 11759668
    [No Abstract]   [Full Text] [Related]  

  • 47. Newly developed colorimetric drug screening assay for Bacillus anthracis.
    Barrow EW; Valderas MW; Bourne PC; Barrow WW
    Int J Antimicrob Agents; 2006 Feb; 27(2):178-80. PubMed ID: 16423510
    [No Abstract]   [Full Text] [Related]  

  • 48. No evidence of a mild form of inhalational Bacillus anthracis infection during a bioterrorism-related inhalational anthrax outbreak in Washington, D.C., in 2001.
    Baggett HC; Rhodes JC; Fridkin SK; Quinn CP; Hageman JC; Friedman CR; Dykewicz CA; Semenova VA; Romero-Steiner S; Elie CM; Jernigan JA
    Clin Infect Dis; 2005 Oct; 41(7):991-7. PubMed ID: 16142664
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Human monoclonal antibodies against anthrax lethal factor and protective antigen act independently to protect against Bacillus anthracis infection and enhance endogenous immunity to anthrax.
    Albrecht MT; Li H; Williamson ED; LeButt CS; Flick-Smith HC; Quinn CP; Westra H; Galloway D; Mateczun A; Goldman S; Groen H; Baillie LW
    Infect Immun; 2007 Nov; 75(11):5425-33. PubMed ID: 17646360
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Prophylaxis of anthrax by antibiotics].
    Kebedzhiev G
    Antibiotiki; 1970 Jan; 15(1):89-93. PubMed ID: 4986116
    [No Abstract]   [Full Text] [Related]  

  • 51. A review of the interaction of Bacillus anthracis with cells of the innate immune response.
    Mayer-Scholl A
    Berl Munch Tierarztl Wochenschr; 2006; 119(5-6):216-21. PubMed ID: 16729468
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Penicillin-produced changes in Bac. anthracis. I. Attempted production of the L-form bacteria].
    NESTOR ID
    Antibiotiki; 1962 Mar; 7():71-5. PubMed ID: 14479097
    [No Abstract]   [Full Text] [Related]  

  • 53. Molecular characterization of Korean Bacillus anthracis isolates by amplified fragment length polymorphism analysis and multilocus variable-number tandem repeat analysis.
    Ryu C; Lee K; Hawng HJ; Yoo CK; Seong WK; Oh HB
    Appl Environ Microbiol; 2005 Aug; 71(8):4664-71. PubMed ID: 16085861
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Feeding Anthrax: The Crystal Structure of Bacillus anthracis InhA Protease.
    Schacherl M; Baumann U
    Structure; 2016 Jan; 24(1):1-2. PubMed ID: 26745525
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Characterization of Bacillus anthracis-like bacteria isolated from wild great apes from Cote d'Ivoire and Cameroon.
    Klee SR; Ozel M; Appel B; Boesch C; Ellerbrok H; Jacob D; Holland G; Leendertz FH; Pauli G; Grunow R; Nattermann H
    J Bacteriol; 2006 Aug; 188(15):5333-44. PubMed ID: 16855222
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Confirmation of Bacillus anthracis from flesh-eating flies collected during a West Texas anthrax season.
    Blackburn JK; Curtis A; Hadfield TL; O'Shea B; Mitchell MA; Hugh-Jones ME
    J Wildl Dis; 2010 Jul; 46(3):918-22. PubMed ID: 20688697
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Efficacy and durability of Bacillus anthracis bacteriophages used against spores.
    Walter MH
    J Environ Health; 2003; 66(1):9-15, 24; quiz 27-8. PubMed ID: 12879575
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Amino acid composition of the capsular substance of anthrax bacilli and serologically identical specific substance of B. mesentericus].
    PONGOR G
    Experientia; 1950 Nov; 6(11):421. PubMed ID: 14793534
    [No Abstract]   [Full Text] [Related]  

  • 59. [Rate of spreading of Bacillus anthracis during various methods of therapy of cutaneous forms of anthrax].
    NIKIFOROV VN
    Zh Mikrobiol Epidemiol Immunobiol; 1960 Sep; 31():118-24. PubMed ID: 13729053
    [No Abstract]   [Full Text] [Related]  

  • 60. [Differentiation of Bacillus anthracis and similar sporogenic bacilli, and the significance of their occurrence in waste water].
    GILLISSEN G; LUST D
    Zentralbl Bakteriol Orig; 1950 Oct; 156(2):99-107. PubMed ID: 14798922
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.